Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Thummel

Showing results (41-50 of 159) with videos related to

Pageof 16
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 7, 2023
Translating Kratom-Drug Interactions: From Bedside to Bench and BackRakshit S Tanna, Nadja B Cech, Nicholas H Oberlies, et al.
The Journal of Clinical Investigation|May 13, 2006
Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalaciaChangcheng Zhou, Mahfoud Assem, Jessica C Tay, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2006
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitroYang Dai, Mary F Hebert, Nina Isoherranen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2025
Human enteroid monolayers: A novel, functionally stable model for investigating oral drug dispositionChristopher Arian, Eimear O'Mahony, James W MacDonald, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2024
Human Enteroid Monolayers: A Novel, Functionally-Stable Model for Investigating Oral Drug DispositionChristopher Arian, Eimear O'Mahony, James W MacDonald, et al.
Clinical and Translational Science|October 26, 2021
Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approachEmily J Cox, Allan E Rettie, Jashvant D Unadkat, et al.
Clinical Chemistry|September 13, 2012
Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometryThomas J Laha, Frederick G Strathmann, Zhican Wang, et al.
Pharmacology Research & Perspectives|July 9, 2025
Extending Investigations of miR-126-5p on the Regulation of CYP2A6, the Major Nicotine-Inactivating EnzymeWeilong Gu, Alec W R Langlois, Haidy Giratallah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 2013
Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactionsYoshiyuki Shirasaka, Shu-Ying Chang, Mary F Grubb, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2015
Variability in Expression of CYP3A5 in Human Fetal LiverCarrie A Vyhlidal, Robin E Pearce, Roger Gaedigk, et al.
Pageof 16

Showing results (41-50 of 159) with videos related to

Sort By:
Pageof 16
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 7, 2023
Translating Kratom-Drug Interactions: From Bedside to Bench and BackRakshit S Tanna, Nadja B Cech, Nicholas H Oberlies, et al.
The Journal of Clinical Investigation|May 13, 2006
Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalaciaChangcheng Zhou, Mahfoud Assem, Jessica C Tay, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 28, 2006
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitroYang Dai, Mary F Hebert, Nina Isoherranen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 30, 2025
Human enteroid monolayers: A novel, functionally stable model for investigating oral drug dispositionChristopher Arian, Eimear O'Mahony, James W MacDonald, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 14, 2024
Human Enteroid Monolayers: A Novel, Functionally-Stable Model for Investigating Oral Drug DispositionChristopher Arian, Eimear O'Mahony, James W MacDonald, et al.
Clinical and Translational Science|October 26, 2021
Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approachEmily J Cox, Allan E Rettie, Jashvant D Unadkat, et al.
Clinical Chemistry|September 13, 2012
Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometryThomas J Laha, Frederick G Strathmann, Zhican Wang, et al.
Pharmacology Research & Perspectives|July 9, 2025
Extending Investigations of miR-126-5p on the Regulation of CYP2A6, the Major Nicotine-Inactivating EnzymeWeilong Gu, Alec W R Langlois, Haidy Giratallah, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 1, 2013
Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactionsYoshiyuki Shirasaka, Shu-Ying Chang, Mary F Grubb, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2015
Variability in Expression of CYP3A5 in Human Fetal LiverCarrie A Vyhlidal, Robin E Pearce, Roger Gaedigk, et al.
Pageof 16